HC Wainwright restated their buy rating on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research report released on Wednesday morning, Benzinga reports. They currently have a $2.00 target price on the stock. A number of other equities analysts also recently commented on the company. Cantor Fitzgerald restated a neutral rating and set […]
StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research report released on Monday. The firm issued a sell rating on the stock. Several other equities analysts have also issued reports on ONCT. HC Wainwright raised shares of Oncternal Therapeutics from a neutral rating to a buy rating and set […]
Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $2.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 238.41% from the stock’s current price. […]
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal. Ascent Industries shares surged 7.4% to $8.69 in pre-market trading.